Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemia

INTRODUCTION: Nicotinic acid (NA) has been associated with reduced cardiovascular morbidity and mortality. Of note, beyond its lipid-modifying actions, NA possesses a number of not yet thoroughly defined pleiotropic actions including anti-inflammatory and antithrombotic effects. As a growing body of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kei, Anastazia, Elisaf, Moses
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107250/
https://www.ncbi.nlm.nih.gov/pubmed/25097572
http://dx.doi.org/10.5114/aoms.2014.43738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107250/
https://www.ncbi.nlm.nih.gov/pubmed/25097572
http://dx.doi.org/10.5114/aoms.2014.43738

Ejemplares similares